Abstract:Objective: Urinary N-acetyl-β-glucosaminidase(NAGase) and Retinal-binding protein(RBP) has been applied as sensitive clinical markers of acute tubulointerstial damage s. Further study is in need to evaluate their relevance with pathological change s and clinical functional changes in different entities of tubulointerstitial di sorders and glomerular diseases. In this study, we explored the relevance of the se markers with the tubulointerstitial lesion and glomerular function in classic al tubulointerstitial disorders as chronic aristolochic acid nephropathy (CAAN) and Sjogren syndrome related nephropathy (SSN), and in glomerulonephropathy as I gA nephropathy (IgAN) and lupus nephropathy (LN). Methodology:This study included 9 patients with SSN, 14 patients with CAAN, 169 patients wit h IgAN and 83 patients with type-Ⅳ or type-Ⅴ LN. All patients were hospitali zed for evaluation, and underwent a renal biopsy. Urinary RBP and NAGase were de termined with ELISA and colourimetric assay respectively. Other laboratory tests including urinary C3, urinary α 2M, 24 hour urinary protein excetion, and ser um creatinine (SCr) were studied. Histological changes of renal biopsy slides we re reviewed and graded semi-quantitatively according to the extent of tubulointe rstitial lesion. Changes of urinary RBP and NAG and their relationship with tubu lar interstitial damage were analyzed, with respect to the four different groups of patients. Influencing factors on urinary RBP and NAG were explored. Results:In patients with Sjogren's disease, CAAN, IgAN and LN, the percentages of patien ts with increased urine RBP and NAG were 100% and 88.89%、85.71% and 71.43 %、37.28% and 56.21%,69.88% and 97.59%, respectively. RBP and NAG excr etion increased while tubular-interstitial lesion deteriorate. In SSN and CAAN, The urinary excretion of RBP and NAG had no significant co-relationship with th at of urinary C3 and α 2M (P0.05). There is no significant change of uri nary RBP and NAG when SCr increase (P0.05). In IgAN, The excretion of RBP had significant co-relationship with that of urinary C3(P0.01), the exc retion of NAG had significant co-relationship with that of urinary C3 and α 2 M(P0.01). RBP and NAG excretion increased while 24h urine protein excret ion or SCr raised. In LN, The excretion of RBP and NAG had significant co-relat ionship with that of urinary C3 and α 2M respectively(P0.01). The excr etion of NAG increased when 24h urine protein aggrandized(P0.05)and that of RBP increased along with SCr. Conclusion:Examinations of urine RBP and NAG are effective methods for assessing renal tubu lar interstitial lesion. Urine RBP and NAG levels correlate with tubular interst itial historical change and show various characters in different nephropathies. In patients characterized by tubulointerstitial lesion, such as SSN and CAAN, ur inary RBP and urinary NAG correlated well with the extent of tubulointerstitial changes. In patients characterized by glomerular lesion and accompanied tubuloin terstitial changes, the extent of using RBP and urinary NAG are influenced by fa ctors including 24-hour urinary protein excretion, urinary protein selectivity, and serum levels of creatinine.

Detection and Clinical Significance of Angiostatin in Urine of Patients with Glomerular Disease

Urinary Angiostatin: a Novel Biomarker of Kidney Disease Associated with Disease Severity and Progression.

Value of urinary C-terminal agrin fragment in monitoring the progression of early kidney injury in type 2 diabetic patients

Non-invasive detection of acute renal allograft rejection by measurement of vascular endothelial growth factor in urine.

Prediction of Subclinical Renal Allograft Rejection by Vascular Endothelial Growth Factor in Serum and Urine.

ELISA Examining Urinary Angiotensinogen As a Potential Indicator of Intrarenal Renin–angiotensin System (RAS) Activity: a Clinical Study of 128 Chronic Kidney Disease Patients

Correlation Between Urinary Angiotensinogen and Intrarenal Renin-Angiotensin System Activity in Chronic Kidney Disease Patients

Urinary Serum- and Glucocorticoid-Inducible Kinase SGK1 Reflects Renal Injury in Patients with Immunoglobulin A Nephropathy

Acute Renal Allograft Rejection is Associated with Increased Levels of Vascular Endothelial Growth Factor in the Urine

Clinical Application of the Urinary Markers of Renal Tubular Injury

Urinary Angiotensinogen is Elevated in Patients with Nephrolithiasis

Clinical Significance of Urinary Biomarkers in Patients with Primary Focal Segmental Glomerulosclerosis.

Clinical Significance of Serum and Urinary VEGF in IgA Nephropathy

Expression and Application of Serum NGAL, KIM-1 and CysC in Patients with Renal Tumor

Clinical Significance of Serum and Urine Angiopoietin-Like 3 and 4 in Children with Primary Nephrotic Syndrome

The Significance of Urinary Angiotensinogen for Renal Injury in Diabetic Patients Without Hypertension

Study on the Clinical Significance of Serum Cystatin C in Different Stage of Renal Impairment in Type 2 Diabetic Patients

Correlation of urinary angiotensinogen with the crescent formation in IgA nephropathy patients

Clinical Value of Urinary Kidney Biomarkers for Estimation of Renal Impairment in Elderly Chinese with Essential Hypertension

Plasma neutrophil gelatinase-associated lipocalin predicts renal tubulointerstitial injury in patients with IgA nephropathy

The significance of urinary neutrophil gelatinase-associated lipocalin in the early diagnosis of diabetic nephropathy